Your session is about to expire
← Back to Search
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up in past 6 months, at 1 and 2 years post-intervention
Awards & highlights
Study Summary
This trial found that SBIRT was effective in reducing AOD use among adolescents.
Who is the study for?
This trial is for adolescent primary care providers and their patients aged 12-18 at a specific pediatric clinic. It aims to assess methods to reduce youth alcohol and drug use. Providers outside this clinic or patient records not from this site are excluded.Check my eligibility
What is being tested?
The study is testing two approaches of Screening, Brief Intervention, and Referral to Treatment (SBIRT) in a pediatrics clinic setting to see which is more effective at reducing alcohol and other drug use among adolescents.See study design
What are the potential side effects?
Since the interventions involve screening and behavioral strategies rather than medications, there are no direct physical side effects like those associated with drugs; however, there may be psychological impacts due to discussing substance use.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ use in past 6 months, at 1 and 2 years post-intervention
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~use in past 6 months, at 1 and 2 years post-intervention
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Assessment rate
Brief Intervention rate
Problem Identification rate
+2 moreSecondary outcome measures
Alcohol and other drug use
Specialty Behavioral Health Treatment Initiation
Substance Use-related outcomes
Trial Design
3Treatment groups
Experimental Treatment
Active Control
Group I: Primary Care PhysicianExperimental Treatment1 Intervention
If the adolescent is identified at risk for substance use, the screening and brief intervention referral to treatment delivered is by the primary care physician
Group II: Behavioral Medicine SpecialistExperimental Treatment1 Intervention
If the adolescent is identified at risk for substance use, the screening and brief intervention referral to treatment delivered by the behavioral medicine specialist
Group III: Usual CareActive Control1 Intervention
Care is administered as usual
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Primary Care Physician
2017
N/A
~150
Find a Location
Who is running the clinical trial?
Kaiser PermanenteLead Sponsor
538 Previous Clinical Trials
24,104,744 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am between 12 and 18 years old and my health records are at a pediatric care facility.
Research Study Groups:
This trial has the following groups:- Group 1: Primary Care Physician
- Group 2: Usual Care
- Group 3: Behavioral Medicine Specialist
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is participation in this experiment available to enrollees at the present time?
"This medical investigation, initially posted on October 1st 2011 and last updated on September 8th 2022 is not presently seeking participants. Nonetheless, 359 other trials are actively recruiting patients at the moment."
Answered by AI
Are octogenarians being accepted as participants in this experiment?
"This medical experiment is open to applications from individuals between 12 and 80 years old."
Answered by AI
Can I register for this clinical trial?
"This clinical trial seeks to enrol 9084 individuals of ages 12 through 80 with a history of substance misuse. To qualify, applicants must meet the following criteria: primary care providers at the pediatric clinic will be considered, there are two distinct study populations necessitating such an expansive age range and all electronic records relating to adolescent patients aged 12-18 from that same clinic shall be evaluated."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger